Australian R&D company MindBio Therapeutics conducted a first-ever Phase 2a take-home microdosing trial to treat depression.. 53% of patients went into complete depression remission after 8 weeks of ...

Two later-stage trials investigating LSD for treating anxiety are due to conclude in 2026, which could lead to the drug being approved for the common mental health condition ...

I became a neuroscientist to help us understand how humans gain deeper insight and observation into themselves, life, and being during altered states of consciousness. I never expected to write a post ...

LSD microdosing could increase the duration of sleep the following night, according to the largest study of its kind. The unexpected finding may help to explain why the practice has been associated ...

The magical and potent hallucinogen lysergic acid diethylamide (LSD) may have a new, clinically significant medical benefit: getting sleep. A new study, entitled “LSD Increases Sleep Duration the ...

Microdosing is gaining popularity with a new breed of health seekers. These self-experimenters take a very small amount of psilocybin mushrooms or LSD to try to reduce anxiety, stress and depression.

Neuro-pharmaceutical and psychedelics company Mind Medicine Inc. MNMD MMED MMQ announced Friday the initiation of Phase 2a proof-of-concept trial of LSD (lysergic acid diethylamide) in adult patients ...

During the initial, pre-vaccine days of the pandemic, Diane, a primary care provider in the D.C. area, saw dozens of her patients die. She started having nightmares, and as the months went on, she ...